Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes

Diabetes

Volumn 58, Issue 6, 2009, Pages 1403-1410

  Pezzolesi, Marcus G ^a   Poznik, G David ^a   Mychaleckyj, Josyf C ^b   Paterson, Andrew D ^c,d   Barati, Michelle T ^e   Klein, Jon B ^e   Ng, Daniel P K ^a,f   Placha, Grzegorz ^a,g   Canani, Luis H ^a,h   Bochenski, Jacek ^a   Waggott, Daryl ⁱ   Merchant, Michael L ^e   Krolewski, Bozena ^a   Mirea, Lucia ^d,i   Wanic, Krzysztof ^a   Katavetin, Pisut ^a   Kure, Masahiko ^a   Wolkow, Pawel ^a,j   Dunn, Jonathon S ^a   Smiles, Adam ^a   Walker, William H ^a   Boright, Andrew P ^k   Bull, Shelley B ^d,i   Doria, Alessandro ^a   Rogus, John J ^a   Rich, Stephen S ^b   Warram, James H ^a   Krolewski, Andrzej S ^a   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF LOUISVILLE   (United States)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g MEDICAL UNIVERSITY OF WARSAW   (Poland)

^h HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

ⁱ MOUNT SINAI HOSPITAL   (Canada)

^j JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^k UNIVERSITY HEALTH NETWORK   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE TRANSFER RNA; EZRIN; MOESIN; RADIXIN;

ADULT; ARTICLE; CARS C GENE; CHN2 C GENE; CONTROLLED STUDY; CPVL C GENE; DIABETIC NEPHROPATHY; FEMALE; FRMD3 GENE; GENE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CHROMOSOME MAPPING; CYTOSKELETAL PROTEINS; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINURIA;

EID: 66649089156     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-1514     Document Type: Article

References (39)

1. Jones CA, Krolewski AS, Rogus J, et al. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int 2005;67:1684-1691
2. Perkins BA, Ficociello LH, Silva KH, et al. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003;348:2285-2293 (Pubitemid 36638102)
3. Parving HH, Mauer M, Ritz E. Diabetic nephropathy. In Brenner and Rector's The Kidney. 7th ed. Brenner BM, Ed. Philadelphia, PA, Elsevier, 2004, p. 1777-1818
4. Perkins BA, Ficociello LH, Ostrander BE, et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol 2007;18:1353-1361 (Pubitemid 46536923)
5. Krolewski M, Eggers PW, Warram JH. Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int 1996;50:2041-2046 (Pubitemid 26417548)
6. Nishimura R, Dorman JS, Bosnyak Z, et al. Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: a report from the Allegheny County registry. Am J Kidney Dis 2003;42:117-124 (Pubitemid 36807660)
7. Seaquist ER, Goetz FC, Rich S, et al. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989;320:1161-1165 (Pubitemid 19124296)
8. Quinn M, Angelico MC, Warram JH, et al. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996;39:940-945 (Pubitemid 26249113)
9. Diabetes Control and Complications Trial Research Group. Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial. Diabetes 1997;46:1829-1839 (Pubitemid 27456418)
10. Ng DP, Krolewski AS. Molecular genetic approaches for studying the etiology of diabetic nephropathy. Curr Mol Med 2005;5:509-525 (Pubitemid 41086776)
11. Freedman BI, Bostrom M, Daeihagh P, et al. Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol 2007;2:1306-1316
12. Placha G, Canani LH, Warram JH, et al. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis 2005;12:155-169 (Pubitemid 40488998)
13. Al-Kateb H, Boright AP, Mirea L, et al. Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study. Diabetes 2008;57:218-228
14. Mueller PW, Rogus JJ, Cleary PA, et al. Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol 2006;17:1782-1790 (Pubitemid 44036161)
15. GAIN Collaborative Research Group. New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat Genet 2007;39:1045-1051 (Pubitemid 47340660)
16. Wanic K, Placha G, Dunn J, et al. Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies. Diabetes 2008;57:2547-2551
17. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986 (Pubitemid 23307905)
18. Epidemiology of Diabetes Interventions and Complications Research Group. Epidemiology of Diabetes Interventions and Complications (EDIC): design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999;22:99-111
19. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575 (Pubitemid 47330214)
20. Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008;40:161-169
21. Lasky-Su J, Lyon HN, Emilsson V, et al. On the replication of genetic associations: timing can be everything! Am J Hum Genet 2008;82:849-858
22. Weedon MN, Lango H, Lindgren CM, et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet 2008;40: 575-583
23. Rogus JJ, Warram JH, Krolewski AS. Genetic studies of late diabetic complications: the overlooked importance of diabetes duration before complication onset. Diabetes 2002;51:1655-1662 (Pubitemid 34564275)
24. Yuan S, Miller DW, Barnett GH, et al. Identification and characterization of human beta 2-chimaerin: association with malignant transformation in astrocytoma. Cancer Res 1995;55:3456-3461
25. Mahoney JA, Ntolosi B, DaSilva RP, et al. Cloning and characterization of CPVL, a novel serine carboxypeptidase, from human macrophages. Genomics 2001;72:243-251 (Pubitemid 32281525)
26. Ni X, Ji C, Cao G, et al. Molecular cloning and characterization of the protein 4.1O gene, a novel member of the protein 4.1 family with focal expression in ovary. J Hum Genet 2003;48:101-106 (Pubitemid 36305864)
27. Hoover KB, Bryant PJ. The genetics of the protein 4.1 family: organizers of the membrane and cytoskeleton. Curr Opin Cell Biol 2000;12:229-234 (Pubitemid 30142571)
28. Ramez M, Blot-Chabaud M, Cluzeaud F, et al. Distinct distribution of specific members of protein 4.1 gene family in the mouse nephron. Kidney Int 2003;63:1321-1337 (Pubitemid 36349998)
29. Chishti AH, Kim AC, Marfatia SM, et al. The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci 1998;23:281-282 (Pubitemid 28461889)
30. Baines AJ. A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function. BMC Genomics 2006;7:85
31. Sheppard K, Yuan J, Hohn MJ, et al. From one amino acid to another: tRNA-dependent amino acid biosynthesis. Nucleic Acid Res 2008;36:1813-1825
32. Antonellis A, Green ED. The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet 2008;9:87-107
33. Waterson JR, Winter WP, Schmickel RD. Cysteine activation in cultured cystinotic cells: the specific activity of cysteinyl-tRNA synthetase and tRNACys and the determination of the Michaelis-Menten constants for cysteinyl-tRNA synthetase. J Clin Invest 1974;54:182-187
34. Gahl WA, Thoene JG, Schneider JA. Cystinosis. N Engl J Med 2002;347: 111-121
35. Town M, Jean G, Cherqui S, et al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 1998;18:319-324 (Pubitemid 28158158)
36. Adler S. Diabetic nephropathy: linking histology, cell biology, and genetics. Kidney Int 2004;66:2095-2106
37. Riad A, Zhuo JL, Schultheiss HP, et al. The role of the renal kallikrein-kinin system in diabetic nephropathy. Curr Opin Nephrol Hypertens 2007;16: 22-26 (Pubitemid 44885737)
38. Vats KR, Ishwad C, Singla I, et al. A locus for renal malformations including vesico-ureteric reflux on chromosome 13q33-34. J Am Soc Nephrol 2006; 17:1158-1167
39. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316:1341-1345 (Pubitemid 46871655)